• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酵母中突变型亨廷顿蛋白片段的细胞毒性可受野生型亨廷顿蛋白片段表达水平的调节。

Cytotoxicity of mutant huntingtin fragment in yeast can be modulated by the expression level of wild type huntingtin fragment.

作者信息

Saleh Aliabbas Ahmedbhai, Bhadra Ankan Kumar, Roy Ipsita

机构信息

Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER) , Sector 67, S.A.S. Nagar, Punjab 160 062, India.

出版信息

ACS Chem Neurosci. 2014 Mar 19;5(3):205-15. doi: 10.1021/cn400171d. Epub 2014 Jan 8.

DOI:10.1021/cn400171d
PMID:24377263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3963126/
Abstract

Conflicting reports exist in the literature regarding the role of wild-type huntingtin in determining the toxicity of the aggregated, mutant huntingtin in Huntington's disease (HD). Some studies report the amelioration of toxicity of the mutant protein in the presence of the wild-type protein, while others indicate sequestration of the wild-type protein by mutant huntingtin. Over the years, yeast has been established as a valid model organism to study molecular changes associated with HD, especially at the protein level. We have used an inducible system to express human huntingtin fragments harboring normal (25Q) and pathogenic (103Q) polyglutamine lengths under the control of a galactose promoter in a yeast model of HD. We show that the relative expression level of each allele (wild-type/mutant) decides the cellular phenotype. When the expression level of wild-type huntingtin is high, an increase in the solubility of the mutant protein is observed. Fluorescence-recovery-after-photobleaching (FRAP) studies show that solubility reaches ∼94% in these cells. This leads to reduction in oxidative stress and cytotoxicity, and increases cell viability. In-cell FRET studies show that interaction between these proteins does not require the presence of a mediator. When the expression of wild-type huntingtin is low, it is sequestered into aggregates by the mutant protein. Even under these conditions, cytotoxicity is attenuated. Our findings indicate that the presence of wild-type huntingtin has a beneficial role even when its relative expression level is lower than that of the mutant protein.

摘要

关于野生型亨廷顿蛋白在亨廷顿舞蹈病(HD)中决定聚集的突变型亨廷顿蛋白毒性方面所起的作用,文献中有相互矛盾的报道。一些研究报告称,在野生型蛋白存在的情况下,突变蛋白的毒性会减轻,而另一些研究则表明突变型亨廷顿蛋白会隔离野生型蛋白。多年来,酵母已被确立为研究与HD相关分子变化的有效模式生物,尤其是在蛋白质水平上。我们使用了一种诱导系统,在HD酵母模型中,在半乳糖启动子的控制下表达具有正常(25Q)和致病(103Q)多聚谷氨酰胺长度的人类亨廷顿蛋白片段。我们发现,每个等位基因(野生型/突变型)的相对表达水平决定了细胞表型。当野生型亨廷顿蛋白的表达水平较高时,会观察到突变蛋白的溶解度增加。光漂白后荧光恢复(FRAP)研究表明,在这些细胞中溶解度达到约94%。这导致氧化应激和细胞毒性降低,并提高细胞活力。细胞内荧光共振能量转移(FRET)研究表明,这些蛋白质之间的相互作用不需要介质的存在。当野生型亨廷顿蛋白的表达水平较低时,它会被突变蛋白隔离到聚集体中。即使在这些条件下,细胞毒性也会减弱。我们的研究结果表明,即使野生型亨廷顿蛋白的相对表达水平低于突变蛋白,其存在也具有有益作用。

相似文献

1
Cytotoxicity of mutant huntingtin fragment in yeast can be modulated by the expression level of wild type huntingtin fragment.酵母中突变型亨廷顿蛋白片段的细胞毒性可受野生型亨廷顿蛋白片段表达水平的调节。
ACS Chem Neurosci. 2014 Mar 19;5(3):205-15. doi: 10.1021/cn400171d. Epub 2014 Jan 8.
2
Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III.突变型亨廷顿蛋白片段在酵母中的细胞毒性涉及线粒体氧化磷酸化复合物II和III的早期改变。
Hum Mol Genet. 2006 Oct 15;15(20):3063-81. doi: 10.1093/hmg/ddl248. Epub 2006 Sep 12.
3
Cellular toxicity of yeast prion protein Rnq1 can be modulated by N-terminal wild type huntingtin.酵母朊病毒蛋白Rnq1的细胞毒性可被N端野生型亨廷顿蛋白调节。
Arch Biochem Biophys. 2016 Jan 15;590:82-89. doi: 10.1016/j.abb.2015.11.036. Epub 2015 Nov 26.
4
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.突变型亨廷顿蛋白对小鼠纹状体基因表达的影响重现了在人类亨廷顿病大脑中观察到的变化,且与突变型亨廷顿蛋白的长度或野生型亨廷顿蛋白的剂量无关。
Hum Mol Genet. 2007 Aug 1;16(15):1845-61. doi: 10.1093/hmg/ddm133. Epub 2007 May 21.
5
Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.突变亨廷顿蛋白的淀粉样蛋白形成:阈值、渐进性及正常多聚谷氨酰胺蛋白的募集
Somat Cell Mol Genet. 1998 Jul;24(4):217-33. doi: 10.1023/b:scam.0000007124.19463.e5.
6
A cellular model that recapitulates major pathogenic steps of Huntington's disease.一种概括亨廷顿舞蹈症主要致病步骤的细胞模型。
Hum Mol Genet. 1998 Sep;7(9):1355-61. doi: 10.1093/hmg/7.9.1355.
7
Activation of salt shock response leads to solubilisation of mutant huntingtin in Saccharomyces cerevisiae.盐休克反应的激活导致酿酒酵母中突变亨廷顿蛋白的溶解。
Cell Stress Chaperones. 2014 Sep;19(5):667-73. doi: 10.1007/s12192-014-0492-9. Epub 2014 Jan 26.
8
Tissue transglutaminase selectively modifies proteins associated with truncated mutant huntingtin in intact cells.组织转谷氨酰胺酶在完整细胞中选择性修饰与截短突变型亨廷顿蛋白相关的蛋白质。
Neurobiol Dis. 2001 Jun;8(3):391-404. doi: 10.1006/nbdi.2001.0390.
9
Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease.突变型亨廷顿蛋白促进野生型亨廷顿蛋白的纤维形成:亨廷顿舞蹈症中亨廷顿蛋白功能丧失的一种潜在机制。
J Biol Chem. 2003 Oct 17;278(42):41452-61. doi: 10.1074/jbc.M303354200. Epub 2003 Jul 29.
10
Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease.野生型亨廷顿蛋白可降低亨廷顿舞蹈病哺乳动物细胞模型中突变型亨廷顿蛋白的细胞毒性。
J Med Genet. 2001 Jul;38(7):450-2. doi: 10.1136/jmg.38.7.450.

引用本文的文献

1
Reviewing the Structure-Function Paradigm in Polyglutamine Disorders: A Synergistic Perspective on Theoretical and Experimental Approaches.综述多聚谷氨酰胺疾病的结构-功能范式:理论和实验方法的协同视角。
Int J Mol Sci. 2024 Jun 20;25(12):6789. doi: 10.3390/ijms25126789.
2
Phase Transition of Huntingtin: Factors and Pathological Relevance.亨廷顿蛋白的相变:因素及病理相关性
Front Genet. 2020 Jul 23;11:754. doi: 10.3389/fgene.2020.00754. eCollection 2020.
3
FRET Microscopy in Yeast.酵母中的荧光共振能量转移(FRET)显微镜技术。
Biosensors (Basel). 2019 Oct 11;9(4):122. doi: 10.3390/bios9040122.
4
Neurotheranostics as personalized medicines.神经治疗学作为个性化药物。
Adv Drug Deliv Rev. 2019 Aug;148:252-289. doi: 10.1016/j.addr.2018.10.011. Epub 2018 Oct 26.
5
Studying Huntington's Disease in Yeast: From Mechanisms to Pharmacological Approaches.在酵母中研究亨廷顿舞蹈症:从机制到药理学方法
Front Mol Neurosci. 2018 Sep 4;11:318. doi: 10.3389/fnmol.2018.00318. eCollection 2018.
6
Saccharomyces genome database informs human biology.酿酒酵母基因组数据库为人类生物学提供信息。
Nucleic Acids Res. 2018 Jan 4;46(D1):D736-D742. doi: 10.1093/nar/gkx1112.
7
Multiple discrete soluble aggregates influence polyglutamine toxicity in a Huntington's disease model system.多种离散的可溶性聚集体影响亨廷顿病模型系统中的多聚谷氨酰胺毒性。
Sci Rep. 2016 Oct 10;6:34916. doi: 10.1038/srep34916.
8
Protein aggregation activates erratic stress response in dietary restricted yeast cells.蛋白质聚集会激活受饮食限制的酵母细胞中不稳定的应激反应。
Sci Rep. 2016 Sep 16;6:33433. doi: 10.1038/srep33433.
9
Wild type huntingtin toxicity in yeast: Implications for the role of amyloid cross-seeding in polyQ diseases.酵母中野生型亨廷顿蛋白的毒性:对淀粉样蛋白交叉播种在多聚谷氨酰胺疾病中作用的启示。
Prion. 2016 May 3;10(3):221-7. doi: 10.1080/19336896.2016.1176659.
10
Huntingtin is required for ER-to-Golgi transport and for secretory vesicle fusion at the plasma membrane.亨廷顿蛋白对于内质网到高尔基体的运输以及质膜处的分泌小泡融合是必需的。
Dis Model Mech. 2014 Dec;7(12):1335-40. doi: 10.1242/dmm.017368. Epub 2014 Oct 31.

本文引用的文献

1
Hsp104 as a key modulator of prion-mediated oxidative stress in Saccharomyces cerevisiae.Hsp104 作为酿酒酵母朊病毒介导的氧化应激的关键调节因子。
Biochem J. 2013 Sep 1;454(2):217-25. doi: 10.1042/BJ20121806.
2
Fine mapping of autophagy-related proteins during autophagosome formation in Saccharomyces cerevisiae.酵母自噬体形成过程中自噬相关蛋白的精细作图。
J Cell Sci. 2013 Jun 1;126(Pt 11):2534-44. doi: 10.1242/jcs.122960. Epub 2013 Apr 2.
3
Correlation of inter-locus polyglutamine toxicity with CAG•CTG triplet repeat expandability and flanking genomic DNA GC content.基因座间多聚谷氨酰胺毒性与 CAG•CTG 三核苷酸重复扩展能力及侧翼基因组 DNA GC 含量的相关性。
PLoS One. 2011;6(12):e28260. doi: 10.1371/journal.pone.0028260. Epub 2011 Dec 6.
4
A screen for enhancers of clearance identifies huntingtin as a heat shock protein 90 (Hsp90) client protein.一种用于增强清除率的筛选方法鉴定出亨廷顿蛋白为热休克蛋白 90(Hsp90)的伴侣蛋白。
J Biol Chem. 2012 Jan 6;287(2):1406-14. doi: 10.1074/jbc.M111.294801. Epub 2011 Nov 28.
5
Huntingtin aggregation kinetics and their pathological role in a Drosophila Huntington's disease model.亨廷顿病果蝇模型中亨廷顿蛋白聚集的动力学及其病理作用。
Genetics. 2012 Feb;190(2):581-600. doi: 10.1534/genetics.111.133710. Epub 2011 Nov 17.
6
In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production.在体外和体内,亨廷顿蛋白片段的聚集直接导致自由基的产生。
J Biol Chem. 2011 Dec 30;286(52):44512-20. doi: 10.1074/jbc.M111.307587. Epub 2011 Oct 7.
7
Protein expression regulation under oxidative stress.氧化应激下的蛋白质表达调控。
Mol Cell Proteomics. 2011 Dec;10(12):M111.009217. doi: 10.1074/mcp.M111.009217. Epub 2011 Sep 20.
8
Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.亨廷顿病中线粒体动态异常、线粒体缺失和突变亨廷顿寡聚体:对选择性神经元损伤的影响。
Hum Mol Genet. 2011 Apr 1;20(7):1438-55. doi: 10.1093/hmg/ddr024. Epub 2011 Jan 21.
9
Huntington's disease: from molecular pathogenesis to clinical treatment.亨廷顿病:从分子发病机制到临床治疗。
Lancet Neurol. 2011 Jan;10(1):83-98. doi: 10.1016/S1474-4422(10)70245-3.
10
Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro.α-突触核蛋白在体内和体外促进 SNARE 复合物的组装。
Science. 2010 Sep 24;329(5999):1663-7. doi: 10.1126/science.1195227. Epub 2010 Aug 26.